NuGene International Inc (NUGN) has released an update.
On January 25, 2024, a company secured an Equity Line of Credit financing deal, allowing them to sell up to $500,000 worth of common stock shares at a discounted rate to an accredited investor. Additionally, the investor has the option to acquire warrants for a potential $15 million investment in the company’s shares over the next five years. The agreement includes a commitment by the company to facilitate the resale of these securities and adheres to standard legal and regulatory provisions, with the deal successfully closing on the same date.
For further insights into NUGN stock, check out TipRanks’ Stock Analysis page.
